These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 3056553

  • 1. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia.
    Miyamura K, Kojima S, Takeyama K, Matsushita T, Fukuda M, Horibe K, Minami S, Morishima Y, Matsuyama K, Kodera Y.
    Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D, Giardini C, Galimberti M, Lucarelli G, Angelucci E, Polchi P, Baronciani D, Erer B, Sotti G.
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [Abstract] [Full Text] [Related]

  • 3. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
    Reiter E, Keil F, Brugger S, Kalhs P, Rabitsch W, Hinterberger W, Fischer G, Rosenmayr A, Haas O, Volc B, Lechner K, Greinix HT.
    Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
    [Abstract] [Full Text] [Related]

  • 4. Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up.
    Zapatero A, Marín A, López M, Martín De Vidales C, Cerezo L, Domínguez P, Pérez Torrubia A.
    Hematol Oncol; 1996 Dec; 14(4):165-72. PubMed ID: 9267462
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K.
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC, Marín P, Carreras E, Aguilar JL, Grañena A, Rozman C, Montserrat E.
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. BMT for severe aplastic anemia using cyclosporine.
    May WS, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Griffin CA, Jones RJ, Miller CB, Mellits ED, Vogelsang GB.
    Bone Marrow Transplant; 1993 Jun; 11(6):459-64. PubMed ID: 8334426
    [Abstract] [Full Text] [Related]

  • 9. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H, Childs B, Laver J, Shank B, Brochstein J, Gillio A, Flomenberg N, Young J, Boulad F, Black P.
    Int J Radiat Oncol Biol Phys; 1994 Jul 01; 29(4):847-54. PubMed ID: 8040033
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy.
    Champlin RE, Ho WG, Nimer SD, Gajewski JG, Selch M, Burnison M, Holley G, Yam P, Petz L, Winston DJ.
    Transplantation; 1990 Apr 01; 49(4):720-4. PubMed ID: 2326866
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH, Chen PM, Fan S, Liu JH, Chiou TJ, Hsieh RK.
    Bone Marrow Transplant; 1996 Aug 01; 18(2):273-7. PubMed ID: 8864434
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N, Zabelina T, Renges H, Krüger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuk F, Erttmann R, Kabisch H, Zander AR.
    Ann Hematol; 2002 Nov 01; 81(11):627-31. PubMed ID: 12454700
    [Abstract] [Full Text] [Related]

  • 15. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
    Arranz R, Otero MJ, Ramos R, Steegmann JL, Lamana ML, Tomás JF, de la Cámara R, Figuera A, Vázquez L, Fernádez-Rañada JM.
    Bone Marrow Transplant; 1994 Apr 01; 13(4):383-7. PubMed ID: 8019461
    [Abstract] [Full Text] [Related]

  • 16. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 01; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ, Shepherd JD, Nantel SH, Barnett MJ, Reece DE, Klingemann HG, Chan KW, Spinelli JJ, Sutherland HJ, Phillips GL.
    Clin Invest Med; 1995 Apr 01; 18(2):122-30. PubMed ID: 7788957
    [Abstract] [Full Text] [Related]

  • 18. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ, Park CY, Park YH, Kim YJ, Kim DW, Min WS, Kim CC.
    Bone Marrow Transplant; 2003 Jan 01; 31(2):79-86. PubMed ID: 12621487
    [Abstract] [Full Text] [Related]

  • 19. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC.
    Haematologica; 2001 Mar 01; 86(3):303-10. PubMed ID: 11255278
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.